Cargando…
The JNK Inhibitor XG-102 Protects against TNBS-Induced Colitis
The c-Jun N-terminal kinase (JNK)-inhibiting peptide D-JNKI-1, syn. XG-102 was tested for its therapeutic potential in acute inflammatory bowel disease (IBD) in mice. Rectal instillation of the chemical irritant trinitrobenzene sulfonic acid (TNBS) provoked a dramatic acute inflammation in the colon...
Autores principales: | Reinecke, Kirstin, Eminel, Sevgi, Dierck, Franziska, Roessner, Wibke, Kersting, Sabine, Chromik, Ansgar Michael, Gavrilova, Olga, Laukevicience, Ale, Leuschner, Ivo, Waetzig, Vicki, Rosenstiel, Philip, Herdegen, Thomas, Sina, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302790/ https://www.ncbi.nlm.nih.gov/pubmed/22427801 http://dx.doi.org/10.1371/journal.pone.0030985 |
Ejemplares similares
-
The impact of JNK inhibitor D-JNKI-1 in a murine model of chronic colitis induced by dextran sulfate sodium
por: Kersting, Sabine, et al.
Publicado: (2013) -
Knockout of the c-Jun N-terminal Kinase 2 aggravates the development of mild chronic dextran sulfate sodium colitis independently of expression of intestinal cytokines TNFα, TGFB1, and IL-6
por: Kersting, Sabine, et al.
Publicado: (2013) -
XG-102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double-blind, placebo-controlled, dose-escalating study
por: Deloche, Catherine, et al.
Publicado: (2014) -
Bayesian auction game theory-based DBA for XG symmetrical PON
por: Hussain Mohammadani, Khalid, et al.
Publicado: (2022) -
CNN-XG: A Hybrid Framework for sgRNA On-Target Prediction
por: Li, Bohao, et al.
Publicado: (2022)